Next Article in Journal
Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
Previous Article in Journal
Nerve-Sparing Robotic-Assisted Radical Prostatectomy Based on the Absence of Prostate Imaging-Reporting and Data System ≥3 or Biopsy Gleason Pattern ≥4 in the Peripheral Zone
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 6
10.3390/cancers17060963
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2024, 16(18), 3173.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2024, 16, 3173

by
Chan Su Park
1,
Byung Kyu Park
1,*,
Joung-Ho Han
2,
Kyong Joo Lee
3 and
Kang Ju Son
4
1
Division of Gastroenterology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, Republic of Korea
2
Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju 28644, Republic of Korea
3
Division of Gastroenterology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong 18450, Republic of Korea
4
Department of Policy Research Affairs, National Health Insurance Service Ilsan Hospital, Goyang 10444, Republic of Korea
*
Author to whom correspondence should be addressed.
Cancers 2025, 17(6), 963; https://doi.org/10.3390/cancers17060963
Submission received: 25 February 2025 / Accepted: 27 February 2025 / Published: 13 March 2025
(This article belongs to the Section Cancer Metastasis)
Versions Notes

Error in Table

In the original publication [1], there was a mistake in Table 4 as published. The numerical values of the results described in the text differed from those presented in Table 4. The corrected Table 4 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Park, C.S.; Park, B.K.; Han, J.-H.; Lee, K.J.; Son, K.J. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2024, 16, 3173. [Google Scholar] [CrossRef] [PubMed]
Table 4. Hazard ratio of developing safety outcome events.
Table 4. Hazard ratio of developing safety outcome events.
OutcomesHR of Developing Events (95% CI)
GnP
(n = 1134)		FOLFIRINOX
(n = 1134)		p-Value
Emergency center visit1.0 (ref.)1.046
(0.937–1.168)		0.4221
Febrile neutropenia1.0 (ref.)2.285
(1.864–2.802)		<0.0001
Hospitalization *1.0 (ref.)1.160
(1.056–1.274)		0.0019
* Excluding hospitalization for chemotherapy. Abbreviations: HR, hazard ratio; CI, confidence interval; GnP, gemcitabine plus nab-paclitaxel; ref., reference.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Park, C.S.; Park, B.K.; Han, J.-H.; Lee, K.J.; Son, K.J. Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2024, 16, 3173. Cancers 2025, 17, 963. https://doi.org/10.3390/cancers17060963

AMA Style

Park CS, Park BK, Han J-H, Lee KJ, Son KJ. Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2024, 16, 3173. Cancers. 2025; 17(6):963. https://doi.org/10.3390/cancers17060963

Chicago/Turabian Style

Park, Chan Su, Byung Kyu Park, Joung-Ho Han, Kyong Joo Lee, and Kang Ju Son. 2025. "Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2024, 16, 3173" Cancers 17, no. 6: 963. https://doi.org/10.3390/cancers17060963

APA Style

Park, C. S., Park, B. K., Han, J.-H., Lee, K. J., & Son, K. J. (2025). Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2024, 16, 3173. Cancers, 17(6), 963. https://doi.org/10.3390/cancers17060963

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop